ALLIE VERZANI: Open Payments
NPI 1871379099 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $78 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Gilead Sciences, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $17 |
Products named: SPRAVATO, XIFAXAN, Epclusa, CAPLYTA, REXULTI, Dexcom G6 Transmitter.
Industry payments across NE — which companies pay providers there.
